Health
Oxford-AstraZeneca vaccine shows promise in elderly, trial results by Christmas – ABC News
AstraZeneca and Oxford University’s potential COVID-19 vaccine produces a strong immune response in those aged over 70.
Oxford University and AstraZeneca’s potential COVID-19 vaccine produced a strong immune response in older adults, newly published data has showed, with researchers expecting to release late-stage trial results by Christmas.
Key points:
- Late stage Oxford-AstraZeneca trials have shown it develops antibody and T-cell responses in elderly patients
- Rival drugmakers Pfizer-BioNTech and Moderna have recently pushed ahead in the race for a COVID vaccine
- Researchers report no serious side effects from the…
Continue Reading
-
General21 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Noosa News22 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General21 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News11 hours agoSudden death investigation, Maroochydore – Sunshine Coast